Lee Willard T
Known title: Executive Vice PresidentCIK: 0001843620
Associated companies
Transaction History
| THG | ▲ Buy | Grant | 11 | $0 | 9/25/2026 | View on chart |
| THG | ▲ Buy | Grant | 11 | $0 | 6/26/2026 | View on chart |
| THG | ▼ Sell | Open Market | 1,000 | $184K | 5/4/2026 | View on chart |
| THG | ▲ Buy | Grant | 14 | $0 | 3/27/2026 | View on chart |
| THG | ▼ Sell | Tax Withholding | 1,215 | $219K | 2/27/2026 | View on chart |
| THG | ▲ Buy | Grant | 1,154 | $0 | 2/24/2026 | View on chart |
| THG | ▲ Buy | Grant | 744 | $0 | 2/24/2026 | View on chart |
| THG | ▲ Buy | Grant | 793 | $0 | 2/24/2026 | View on chart |
| THG | ▲ Buy | Grant | 12 | $0 | 12/26/2025 | View on chart |
| THG | ▲ Buy | Grant | 12 | $0 | 9/26/2025 | View on chart |
| THG | ▲ Buy | Grant | 13 | $0 | 6/27/2025 | View on chart |
| THG | ▲ Buy | Grant | 12 | $0 | 3/28/2025 | View on chart |
| THG | ▼ Sell | Tax Withholding | 770 | $131K | 2/28/2025 | View on chart |
| THG | ▲ Buy | Grant | 773 | $0 | 2/25/2025 | View on chart |
| THG | ▲ Buy | Grant | 846 | $0 | 2/24/2025 | View on chart |
| THG | ▲ Buy | Grant | 155 | $0 | 2/24/2025 | View on chart |
| THG | ▲ Buy | Grant | 13 | $0 | 12/27/2024 | View on chart |
| THG | ▲ Buy | Grant | 13 | $0 | 9/27/2024 | View on chart |
| THG | ▲ Buy | Grant | 15 | $0 | 6/28/2024 | View on chart |
| THG | ▼ Sell | Open Market | 1,000 | $136K | 5/7/2024 | View on chart |
| THG | ▲ Buy | Grant | 14 | $0 | 3/28/2024 | View on chart |
| THG | ▲ Buy | Grant | 792 | $0 | 2/27/2024 | View on chart |
| THG | ▲ Buy | Grant | 783 | $0 | 2/26/2024 | View on chart |
| THG | ▲ Buy | Grant | 543 | $0 | 2/26/2024 | View on chart |
| THG | ▼ Sell | Tax Withholding | 620 | $83K | 2/26/2024 | View on chart |
| THG | ▲ Buy | Grant | 15 | $0 | 12/29/2023 | View on chart |
| THG | ▲ Buy | Grant | 15 | $0 | 9/29/2023 | View on chart |
| THG | ▲ Buy | Grant | 15 | $0 | 6/30/2023 | View on chart |
| THG | ▲ Buy | Grant | 13 | $0 | 3/31/2023 | View on chart |
| THG | ▼ Sell | Tax Withholding | 500 | $70K | 2/28/2023 | View on chart |
| THG | ▲ Buy | Grant | 332 | $0 | 2/27/2023 | View on chart |
| THG | ▲ Buy | Grant | 244 | $0 | 2/27/2023 | View on chart |
| THG | ▲ Buy | Grant | 715 | $0 | 2/27/2023 | View on chart |
| THG | ▲ Buy | Grant | 14 | $0 | 12/30/2022 | View on chart |
| THG | ▲ Buy | Grant | 14 | $0 | 9/30/2022 | View on chart |
| THG | ▲ Buy | Grant | 12 | $0 | 6/24/2022 | View on chart |
| THG | ▲ Buy | Grant | 11 | $0 | 3/25/2022 | View on chart |
| THG | ▼ Sell | Tax Withholding | 332 | $46K | 3/7/2022 | View on chart |
| THG | ▲ Buy | Grant | 628 | $0 | 2/28/2022 | View on chart |
| THG | ▲ Buy | Grant | 15 | $0 | 12/30/2021 | View on chart |
| THG | ▲ Buy | Grant | 14 | $0 | 9/24/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Hanover Insurance (THG) Draws Attention for Growth and Valuation
Recent articles highlight Hanover Insurance as a potential growth candidate, citing strong capital allocation and a discounted valuation. These reports suggest the stock may be undervalued relative to its fundamentals. The company is currently trading near its 52-week high, with an average analyst target price of $235.88.
Hanover Insurance (THG) Draws Attention for Growth and Valuation. Recent articles highlight Hanover Insurance as a potential growth candidate, citing strong capital allocation and a discounted valuation. These reports suggest the stock may be undervalued relative to its fundamentals. The company is currently trading near its 52-week high, with an average analyst target price of $235.88.